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Abstract
Background: We have recently shown a high prevalence of diabetes and obesity in rural Cameroon, despite an improved
lifestyle. Diabetes in rural Africa remains underdiagnosed and its role in increasing risk of atherosclerosis in these
populations is unknown. We investigated the prevalence of carotid atherosclerosis and cardiovascular risk factors in a
population of subjects with recently-diagnosed diabetes from rural Cameroon.
Methodology/Principal Findings: In a case-control study, carotid intima-media thickness (IMT) was measured in 74 subjects
with diabetes (diagnosed ,2 years), aged 47–85 and 109 controls comparable for age and sex. Subjects were recruited
during a health campaign conducted in April 2009. Blood glucose control (HbA1c, fasting blood glucose) and major
cardiovascular risk factors (complete lipid panel, blood pressure) were also measured. Mean carotid IMT was higher in
subjects with diabetes than healthy controls at each scanned segment (common, internal carotid and bulb) (P,0.05), except
the near wall of the left bulb. Vascular stiffness tended to be higher and pressure-strain elastic modulus of the left carotid
was increased in subjects with diabetes than controls (P,0.05), but distensibility was similar between the two groups. At
least one plaque .0.9 mm was found in 4%, 45.9% and 20% of diabetic subjects at the common, bulb or internal carotid,
respectively. Only 25% of patients had an HbA1c,7%, while over 41.6% presented with marked hyperglycemia
(HbA1c.9%). The prevalence of diabetic subjects with abnormal levels of LDL-cholesterol, triglycerides, HDL-cholesterol or
blood pressure was 45%, 16.6%, 15% and 65.7%, respectively.
Conclusions: Carotid thickness is increased in subjects with diabetes from a rural area of Cameroon, despite the relatively
recent diagnosis. These findings and the high rate of uncontrolled diabetes in this population support the increasing
concern of diabetes and cardiovascular diseases in African countries and indicate the need for multifaceted health
interventions in urban and rural settings.
Citation: Napoli N, Zardi E, Strollo R, Arigliani M, Daverio A, et al. (2012) Increased Carotid Thickness in Subjects with Recently-Diagnosed Diabetes from Rural
Cameroon. PLoS ONE 7(8): e41316. doi:10.1371/journal.pone.0041316
Editor: Giorgio Sesti, Universita Magna-Graecia di Catanzaro, Italy
Received January 26, 2012; Accepted June 20, 2012; Published August 20, 2012
Copyright:  2012 Napoli et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was funded by an unconditional grant to University Campus Bio-Medico from Farmindustria. Glucometers and strips were kindly offered by
Lifescan Italia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The study was supported by Farmindustria which has granted to University Campus Bio-Medico a special program, named ‘‘Afia
Together’’, for health campaigns in Africa. The funder is an union representing several Italian pharma companies. Glucometers and strips were kindly offered by
Lifescan Italia. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE
policies on sharing data and materials.
* E-mail: n.napoli@unicampus.it
Introduction
It has been reported that by 2030, there will be more than 228
million diabetic patients in developing countries, twice as many as
in the western nations, with the highest rates in the sub-Saharan
region [1].
However, diabetes in African countries has been neglected for
years, and only recently has it risen to the attention of the scientific
community [2,3,4]. Because of the dearth of published clinical
studies, it is believed that the prevalence of diabetes may be
underestimated in African countries, and therefore many patients
with diabetes are left untreated.
Paradoxically, cardiovascular disease accounts for a higher rate
of mortality in developing countries than in developed ones [5],
highlighting the importance of diabetes complications in terms of
mortality and morbidity [6,7].
Poor knowledge by the patients about the condition and
limited access to healthcare, the diagnosis is often made at a late
stage of the disease, when infections, retinopathy, and vascular
complications have already caused irreversible damages [8,9,10].
For this reason, the Medical Research Council of South Africa
has developed a national research program focused on cardio-
vascular diseases, indicated as ‘‘public enemy number 2’’, after
HIV [11].
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So far, however, few studies on diabetes prevalence have been
conducted. We have recently shown a high prevalence of diabetes
and obesity in a rural area of Cameroon, confirming that even in a
setting with a protective environment, diabetes is an important
and neglected health problem [12]. In fact, most patients were
unaware of having diabetes and none was on a regular treatment.
We report on a clinical survey in the same rural area (district of
Baham, North Cameroon), about biochemical features and
atherosclerosis prevalence in diabetic patients relative to age and
sex comparable population.
Methods
Participants
Seventy-nine Cameroonian subjects with diabetes and 130 age
and sex comparable healthy subjects were studied in the district of
Baham, a rural area of Cameroon during a health campaign
started in April 2009. Among all these subjects 5 diabetic and 21
controls were excluded from the final analysis because of lack of
clinical or biochemical data, therefore we here report data on 74
patients with diabetes and 109 controls. The diabetic population
(57% females and 43% males) was in part composed of patients
diagnosed during a previous health campaign conducted in 2007
(52 patients) which clinical and biochemical data have been
published elsewhere [12]. However, in these patients only capillary
glycaemia and anthropometric measures were available. Study
subjects were screened through advertisements and announce-
ments by local authorities or referred by local physicians or health
providers. After being diagnosed in 2007, patients received diet
counseling and assigned to local health providers for follow-up.
Nutritional therapy was advised by a certified dietician of our
team, using dedicated brochures and showing plates with required
food sizes in order to achieve a caloric intake from 1600 to
1400 kcal according to personal needs. Moreover, physical activity
was advised as well even if patients were regularly engaged in daily
activities which required long walks or other physical tasks
(manual labor, agriculture, etc). However, none of those returning
at follow-up was on regular treatment or been screened for chronic
complications. Other 22 patients included in the study were
referred by local physicians as new diagnosed patients. Thus, all
diabetic patients included in this study were considered drug-naı¨ve
and were diagnosed with diabetes for less than 2-years.
Clinical data and measurements
All subjects received a physical examination including blood
pressure, weight, height and waist and hip measurements. Body
mass index (BMI) was calculated (kg/m2). Blood glucose was
measured using a Glucocard blood glucose analyzer (Lifescan,
USA) on capillary blood samples. Blood was drawn after an
overnight fast of at least 12 hours to assess glycated hemoglobin
(HbA1c), creatinine, urea, AST and ALT, total cholesterol, HDL-
cholesterol and triglycerides. Blood samples were sent to and
analyzed at University Campus Bio-Medico laboratories in Rome.
LDL-cholesterol was calculated using the Friedwal’s formula.
Physical activity was expressed as a numerical score and was
defined as sedentary (score of 1: sitting or lying most of the day),
moderately active (score of 2: being on one’s feet more than half of
a day), and very active (score of 3: engaging in regular physical
exercise) [13].
Carotid ultrasonography
An accurate medical history and physical examination were
performed in order to evaluate possible sings of neuropathy and
peripheral vascular disease. The carotid intima-media thickness
(IMT) was used as morphologic index of macrovascular disease
and subclinical atherosclerosis. Carotid IMT is a widely used tool
for the assessment of macrovascular risk and can be used to predict
coronary heart diseases and stroke [14,15]. Both common carotid
arteries were scanned by the same operator using a portable high-
resolution ultrasonographic system (logiq e) equipped with a 5–
13 MHz linear transducer. During sonographic examination, all
patients were put in the supine position and scanning was
performed insonating the vessel in perpendicular orientation,
optimazing B-mode settings of gain, depth, focal zone placement,
and compression to enhance arterial wall structures and image
quality. Measurements were made in on-line mode, where the
lumen-intima interface was regular and parallel to the adventitia,
using an electronic caliper to calculate the distance between the
two echogenic lines that compose the interface of the carotid wall;
regions of interest were at the distal-common carotid artery (1 cm
before the dilation of the carotid bulb), at the carotid bulb and at
the first portion of the internal carotid artery (1 cm after the
dilation of the carotid bulb) by a lateral longitudinal projection.
Carotid IMT was calculated in these three sites, on the near and
the far wall, and the average of six measurements from the right
and left side was used for data analysis. The carotid IMT was
defined as the distance between the media–adventitia interface
and the lumen–intima interface. The same investigator performed
all of the ultrasonographic procedures. A value of IMT .0.9 mm
was used as index of clinical organ injury [16], and a value of IMT
.1.5 mm defined the presence of atherosclerotic plaque [16,17].
Doppler parameters of common carotid and internal carotid
arteries of both sides were also obtained after positioning the
sample volume of the ultrasound beam in the middle of the vessel,
using an insonation angle of 60u between ultrasound beam and the
longitudinal axis of the carotid segment; thus, peak systolic velocity
was assessed, and resistivity and pulsatility indices (RI and PI) were
automatically calculated by the sonographic machine using the
following formulae:
RI~(sV{dV)=sV,
PI~(sV{dV)=mV,
where sV = peak systolic velocity; dV = end diastolic velocity and
mV = mean velocity.
The mean value of four measurements from the right and left
side was used for statistical evaluation.
In accordance with others [18], we also used traditional carotid
indices of arterial stiffness [vascular strain (VS), vascular disten-
sibility (VD), vascular stiffness (VSf) and pressure-strain elastic
modulus (PSEM)] for a better comparison.
VS is the relative change in end diastolic diameter during
pulsatile distension.
VD is the relative change in diameter, whereas, VSf is its
reciprocal measure; in fact, increasing distensibility implies
decreasing stiffness. Finally, PSEM is the pressure change required
for (theoretic) 100% increase in diameter
Stiffness parameters were calculated applying the equations
shown below, according to the cited references:
VS~ sDIA{dDIAð Þ=dDIA,
VD~ 2 sDIA{dDIAð Þ=dDIA½ = sBP{dBPð Þ,
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VSf~ sBP=dBPð Þ½ = sDIA{dDIAð Þ=dDIA,
PSEM~k(sBP{dBP)=VS,
where sDIA = systolic carotid diameter; dDIA = diastolic carotid
diameter; sBP = systolic blood pressure; dBP = diastolic blood
pressure and k = conversion factor from mmHg to Pa
(k = 761023).
These parameters, which have been related to brachial artery
flow motion dilation [19], were measured on both common
carotid arteries 2 cm proximal to the carotid bifurcation at a
plaque-free site by M-Mode ultrasonography with synchronous
ECG; after using a minimum pressure on the carotid to allow
optimal visualization without compressing the artery, the mini-
mum arterial diameter was assessed between the P-wave and R-
wave of the recording ECG whereas, the maximum arterial
diameter was assessed between the R-wave and T-wave.
The mean value of four measurements from the right and left
side was used for statistical evaluation. Composite IMT were
calculated as a mean of IMT from two or three carotid sites,
namely mean IMT from internal carotid, common carotid and
bulb.
Informed Consent
The research protocol was approved from both University
Campus Bio-Medico Ethical Committee and National Bioethics
Committee of Cameroon. Given that most of the population in the
rural villages where the study took place is illiterate and speaking
different dialects, the National Bioethics Committee of Cameroon
approved the use of an oral informed consent. Therefore,
informed consent was community-based and was given orally.
Awareness of the rural population was obtained by health
authorities of the district of Baham and by traditional authorities
(Roi de la Chefferie).
Statistical methods
Results are expressed as mean or proportions with 95%
confidence. Group comparisons were made using t-test for
continuous variables and by chi-squared analysis for categorical
variables (smoking exposure, family history of diabetes, and
physical activity). Data were managed using Excel 2003 (Microsoft
Corp., Redmond, WA) and were analyzed using R for Linux 2.15
(R Foundation for Statistical Computing, Wien, Austria).
Results
Clinical and laboratory data of diabetic patients and healthy
subjects are presented in Table 1. A subgroup of 49 patients with
diabetes were part of a previous survey [12] and were re-evaluated
for the present study. In comparison, significant decrease in terms
of fasting glucose (226.5617.5 vs 182.5612.6, p 0.04) and a slight,
not significant reduction in body weight (77.463.1 vs 72.162.3)
was observed. Analyzing the whole population, there were no
differences in age, sex, BMI between the two studied groups.
Capillary blood glucose and HbA1c were significantly higher in
patients with diabetes compared to healthy subjects ones. Among
patients with diabetes, 41.6% had marked hyperglycemia
(HbA1c.9%) and only 25% achieved a value of HbA1c,7%.
ALT levels were higher in patients with diabetes but the average
fell into the normal range and had no clinical relevance in all
patients. No differences in other clinical or biochemical param-
eters were found. Among subjects with diabetes, 45% had LDL-
cholesterol .100 mg/dL, 16.6% had triglycerides .150 mg/dL,
15% had low HDL-cholesterol (males ,40 mg/dL and females
,50 mg/dL) and 65.7% had high blood pressure (systolic or
diastolic blood pressure .130/85 mmHg, respectively). Patients
with diabetes were significantly more active than control subjects.
All subjects underwent ultrasonographic examination of carotids
(Table 2). Mean IMT (mm) was higher in patients with diabetes
than healthy subjects in all examined segments, except at the near
wall of the left bulb. Accordingly, composite IMT were
significantly higher in subjects with diabetes than controls. Among
the diabetic patients 4%, 45.9% and 20% had an IMT .0.9 mm
at the common, bulb or internal carotid, respectively. An
atherosclerotic plaque with IMT .1.5 mm was found in 1.3%,
13.5% and 12.2% at the common, bulb and internal carotid of
subjects with diabetes, respectively.
There was no significant difference in the mean RI and PI of
common carotid and PI of internal carotid between diabetic
patients and healthy subjects. By contrast, RI of the internal
carotid was significantly higher in diabetics compared to healthy
subjects. Vascular stiffness tended to be higher and PSEM of the
left carotid was increased in subjects with diabetes than controls,
but distensibility was similar between the two groups (Table 2).
Discussion
Cardiovascular disease is still the leading cause of death
worldwide in patients with diabetes, and it is now becoming an
emerging threat for sub-Saharan Africa and other developing
countries [20]. In this study we report on increased carotid
thickness in a population of patients with recently diagnosed
diabetes from rural Cameroon compared with healthy controls.
We also find that most diabetic patients had high HbA1c and most
of them had marked hyperglycemia.
Carotid IMT is a validated measure of generalized atheroscle-
rosis. A thickened carotid IMT correlates with an increased risk of
myocardial infarction and stroke [14,15,21] and it is predictive of
future events of silent brain ischemia [22] and coronary heart
diseases in subjects with type 2 diabetes [23,24].
Diabetes duration is an important factor impacting on carotid
thickening [25,26,27,28]. Liu et al. showed that carotid IMT was
significantly related with the duration of type 2 diabetes for longer
than 2 years [26]. A report by the Insulin Resistance Atheroscle-
rosis Study (IRAS) group on a large multiethnic population
demonstrated that internal carotid IMT of patients with diabetes is
not different from non-diabetic subjects at the time of diagnosis,
but it takes a few years to increase significantly [27,28].
Interestingly, in our study internal carotid IMT was higher in
subjects with diabetes than in healthy controls despite the
relatively short time from diagnosis (less than 2 years). A likely
explanation for this finding is that diabetes had gone undiagnosed
for long time before patients were screened. More than 80% of
diabetes cases in Cameroon are inadequately diagnosed, and the
percentage is even higher in the rural population [29], almost
double the figure compared with Western countries [30].
However, several differences in patients’ features and methodology
make difficult a full comparison between our study and the IRAS.
Although carotid IMT was increased in subjects with diabetes
compared with controls, the number of subjects with plaques
(IMT.1.5 mm) was low and the maximal mean IMT at the
common and internal carotid was generally lower than IMT
shown as predictive for cardiovascular events in longitudinal
studies [15,31]. A lower exposure to recognized risk factors in our
population may be protective. Unfortunately, studies analyzing the
Atherosclerosis and Diabetes in Rural Cameroon
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effect of diabetes on sub-clinical atherosclerosis in sub-Saharan
Africa are limited [32,33,34], and the comparison with our data is
biased by differences in methodology and patients’ features (type of
diabetes, diabetes duration, site of IMT measurement). Moreover,
most of these studies on cardiovascular complications are
conducted in urban areas or are predominantly on populations
of Caucasian ancestry. In a study by Faeh et al. on pre-diabetic
and diabetic patients from the Seychelles (predominantly of
African ethnicity), common carotid IMT was significantly
increased in diabetic patients and showed a substantial progression
across the categories of impaired glucose [34]. The difference was
similar to that found in our study, although the absence of internal
carotid IMT measures (that are much more dependent of the stage
of diabetes) limits the comparison. Of note, similarly to our study,
less than a fifth of the diabetic patients studied by Faeh et al. met
the therapeutic target for blood glucose, blood pressure or blood
cholesterol [35].
These data are relevant given that late diagnosis or intervention
increase the probability of irreversible organ damage progression.
This risk may even be underestimated considering that most of the
patients were off of their glycemic target (about 1.6 times higher
than that reported in Western countries [36]). Patients were also
not seen by physicians or any health providers for diabetes on a
regular basis or screened for diabetic complications. Importantly,
none of them was on a stable glucose-lowering treatment after the
diagnosis. Indeed, prospective intervention studies provided
evidence that blood glucose-lowering medications may reduce
the IMT progression linked to diabetes even during limited time-
frames [37,38]. More importantly, it is well-known that intensive
control of blood glucose prevents 25 to 70% of micro-vascular
complications and reduces mortality by 12% [39]. It is also known
that if started late after the onset of the disease, therapy loses its
beneficial effect on cardiovascular disease [40,41]. Although
health promotion and education programs in Cameroon have
been shown to increase the population’s awareness to diabetes
[42], it is still difficult to ensure the spread of these campaigns over
the country.
Several other countries do not even have a diabetes program
and only a few countries can afford to screen and treat diabetes
complications [43]. Although efforts aimed at enhancing access to
medications have been carried out in the last years, the cost of
medicines is still unaffordable for most of the population and
medical counseling remains extremely low, particularly in the rural
context. For example, only 25% of African countries can provide
insulin in rural areas, a situation virtually unchanged from 10
years ago [44].
In conclusion, our data obtained from a rural area of sub-
Saharan Africa show that carotid thickness is higher in subjects
with diabetes than in healthy controls despite the relatively short
time from diagnosis, suggesting that the disease remains undiag-
nosed and untreated for several years. This finding and the high
rate of uncontrolled diabetes in this population increases the
concern of diabetes in African countries raised and support the
need for multifaceted health interventions in urban and rural
Table 1. Clinical and biochemical features of patients with diabetes and healthy controls.
Patients with diabetes Healthy controls P value
Age, yrs 62.4 (60.2–64.5) 61.3 (59.5–63.1) 0.451
BMI, Kg/m2 28.1 (26.3–29.8) 28.6 (27.3–29.9) 0.621
Waist circumference, cm 98.3 (94.2–102.4) 96.4 (93.6–99.2) 0.448
Systolic blood pressure, mmHg 143 (136–150) 138 (133–143) 0.264
Diastolic blood pressure, mmHg 86 (82–90) 84 (81–87) 0.561
Differential pressure, mmHg 57.4 (52.5–62.3) 54 (50.5–57.5) 0.259
Fasting blood glucose, mg/dl 183 (160–209) 88 (83–92) ,0.001
HbA1c, % 9 (7.6–10.3) 6 (5.5–6.4) ,0.001
Total cholesterol, mg/dl 183.5 (172–195.1) 184 (173.4–194.5) 0.954
HDL cholesterol, mg/dl 59.1 (54.9–63.4) 63.6 (59.9–67.3) 0.117
LDL cholesterol, mg/dl 102.2 (93.2–111.3) 101.4 (92.5–108.9) 0.802
Triglycerides, mg/dl 110.5 (97.8–123.3) 98.2 (85.2–111.2) 0.178
Creatinin, mg/dl 1 (0.9–1) 1.1 (0.8–1.5) 0.277
AST, IU/l 43 (36–51) 37 (29–44) 0.227
ALT, IU/l 28 (23–33) 21 (19–24) 0.013
Physical activity, %
Low 50 (39–61) 9 (4–19) ,0.001
Medium 43 (32–55) 88 (78–94)
High 7 (3–16) 3 (0–10)
Smoking, %
No smoke 89 (79–95) 76 (65–85) ,0.053
Less than 20 cig/day 7 (3–16) 11 (5–20)
More than 20 cig/day 4 (1–12) 13 (7–24)
Family history for diabetes, % 64 (51–74) 75 (63–84) 0.195
Data are means (95% confidence interval).
doi:10.1371/journal.pone.0041316.t001
Atherosclerosis and Diabetes in Rural Cameroon
PLOS ONE | www.plosone.org 4 August 2012 | Volume 7 | Issue 8 | e41316
settings. Considering that the healthcare system in these countries
has not adapted to this new reality, well-planned cost-effective
strategies of prevention and treatment and refined tools to assess
health services and monitor progress are necessary in order to
contrast the upcoming epidemic of diabetes-related complications.
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Table 2. Carotid ultrasound measurements in patients with diabetes and healthy controls.
Patients with diabetes Healthy controls P value
Left common carotid
IMT near wall, mm 0.64 (0.61–0.68) 0.58 (0.56–0.6) 0.001
IMT far wall, mm 0.66 (0.63–0.7) 0.59 (0.57–0.61) ,0.001
PI 1.66 (1.56–1.77) 1.63 (1.56–1.69) 0.601
RI 0.74 (0.73–0.76) 0.73 (0.72–0.74) 0.225
M mode 0.57 (0.53–0.62) 0.62 (0.58–0.66) 0.106
Vascular strain, mm 0.092 (0.085–0.1) 0.1 (0.09–0.11) 0.111
Vascular distensibility, mmHg21 0.0037 (0.0032–0.0041) 0.0041 (0.0037–0.0045) 0.145
Vascular stiffness 19.6 (17.3–21.9) 16.7 (14.9–18.6) 0.054
PSEM, Pa 4.72 (4.03–5.41) 3.83 (3.34–4.31) 0.037
Right common carotid
IMT near wall 0.63 (0.6–0.65) 0.59 (0.57–0.61) 0.017
IMT far wall 0.64 (0.61–0.67) 0.6 (0.58–0.62) 0.043
PI 1.69 (1.57–1.8) 1.55 (1.47–1.63) 0.057
RI 0.74 (0.73–0.76) 0.73 (0.71–0.74) 0.082
M mode 0.55 (0.51–0.59) 0.59 (0.55–0.64) 0.166
Vascular strain, mm 0.089 (0.082–0.096) 0.095 (0.088–0.102) 0.200
Vascular distensibility, mmHg21 0.0035 (0.0031–0.0039) 0.00394 (0.00353–0.00434) 0.146
Vascular stiffness 20.3 (17.9–22.7) 18.1 (15.8–20.4) 0.193
PSEM, Pa 4.89 (4.16–5.62) 4.1 (3.55–4.65) 0.087
Left internal carotid
IMT near wall, mm 0.59 (0.55–0.62) 0.53 (0.52–0.55) 0.005
IMT far wall, mm 0.61 (0.57–0.65) 0.55 (0.52–0.58) 0.032
PI 1.24 (1.14–1.34) 1.17 (1.11–1.22) 0.222
RI 0.65 (0.62–0.68) 0.63 (0.62–0.64) 0.311
Right internal carotid
IMT near wall, mm 0.59 (0.56–0.62) 0.53 (0.51–0.55) ,0.001
IMT far wall, mm 0.62 (0.57–0.67) 0.55 (0.52–0.58) 0.019
PI 1.32 (1.23–1.42) 1.28 (1.21–1.35) 0.45
RI 0.69 (0.66–0.72) 0.65 (0.63–0.66) 0.021
Bulb, left carotids:
IMT near wall, mm 0.69 (0.65–0.73) 0.68 (0.65–0.71) 0.042
IMT far wall, mm 0.81 (0.76–0.87) 0.74 (0.7–0.78) 0.036
Bulb, right carotids:
IMT near wall, mm 0.72 (0.68–0.76) 0.7 (0.66–0.73) 0.449
IMT far wall, mm 0.8 (0.75–0.85) 0.73 (0.7–0.77) 0.037
Composite IMT, mm (Bulb/common carotid) 0.69 (0.66–0.71) 0.63 (0.61–0.65) ,0.001
Composite IMT, mm (Bulb/internal carotid) 0.67 (0.64–0.69) 0.6 (0.59–0.62) ,0.001
Composite IMT, mm (Bulb/common/internal carotid) 0.65 (0.63–0.67) 0.59 (0.58–0.61) ,0.001
Data are mean (95% confidence interval). IMT, Intima-media thickness; PI, pulsatily index; RI, resistive index; PSEM, pressure-strain elastic modulus.
doi:10.1371/journal.pone.0041316.t002
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